Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
Associated Press

Brain Chemical May Be Key To Parkinson's, Drug Addiction, Schizophrenia
May 2,2001

BALTIMORE (AP) - A substance produced by the brain to help cells grow also helps a key chemical messenger do its job, a finding that could shed new light on Parkinson's disease, schizophrenia and drug addiction, researchers say.

The substance, brain-derived neurotrophic factor, has long been known to help brain cells mature and survive. The researchers found that BDNF also helps the messenger dopamine by providing a pathway used to deliver the message.

The findings are reported in Thursday's issue of the journal Nature by Pierre Sokoloff of INSERM, the French equivalent of the National Institutes of Health, and colleagues in Paris and Marseille, France.

Working in mice, the scientists found that BDNF prompts brain cells to produce so-called D3 receptors, one type of the tiny structures to which dopamine binds to deliver its message. So, BDNF may play some role in several conditions involving the dopamine signaling system, such as Parkinson's disease and drug addiction, researchers said.

Brain autopsies of schizophrenia patients have also found higher than normal levels of BDNF, Sokoloff said.

The researchers found that mice lacking BDNF had unusually few D3 receptors. They also found that when they reduced the population of D3 receptors in one part of the brain by chemical injection, they could largely restore the population by injecting BDNF.

In a commentary accompanying the paper, Francis J. White of the Chicago Medical School said substances that bind D3 receptors are effective at treating Parkinson's and reducing cocaine-seeking behavior in animal versions of cocaine addiction. As a result, BDNF may be involved in the effects of the Parkinson's medicine levodopa and in drug addiction, he said.

Ira B. Black, chairman of the department of neuroscience and cell biology at Robert Wood Johnson Medical School in Piscataway, N.J., said new treatments based on the research may be a way off.

"We don't understand enough yet," Black said. "But the important thing here is that the link has been established between BDNF and dopamine, and that's an honest day's work."

Copyright 2001 The Associated Press. All rights reserved.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
Top News
General Health
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001